Published in Clin J Am Soc Nephrol on May 24, 2010
Long-term maintenance therapy using rituximab-induced continuous B-cell depletion in patients with ANCA vasculitis. Clin J Am Soc Nephrol (2014) 1.28
Decreased CD5⁺ B cells in active ANCA vasculitis and relapse after rituximab. Clin J Am Soc Nephrol (2013) 1.12
B-cell depletion in the treatment of lupus nephritis. Nat Rev Nephrol (2012) 1.05
Rituximab for the treatment of relapses in antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheumatol (2014) 0.99
Rituximab in induction therapy for anti-neutrophil cytoplasmic antibody (ANCA) vasculitis. Clin Exp Immunol (2011) 0.89
Treatment of renal manifestations of ANCA-associated vasculitis. J Nephropathol (2013) 0.84
Should Pneumocystis jiroveci prophylaxis be recommended with Rituximab treatment in ANCA-associated vasculitis? Clin Rheumatol (2013) 0.80
Rituximab as an immunosuppressant in antineutrophil cytoplasmic antibody-associated vasculitis. Nephrol Dial Transplant (2015) 0.80
Current therapy of granulomatosis with polyangiitis and microscopic polyangiitis: the role of rituximab. J Nephrol (2014) 0.80
Cellular targeting in autoimmunity. Curr Allergy Asthma Rep (2012) 0.80
Efficacy and safety of rituximab as maintenance therapy for relapsing granulomatosis with polyangiitis—a case series. Clin Rheumatol (2014) 0.79
Experience with rituximab in the treatment of antineutrophil cytoplasmic antibody associated vasculitis. Ther Adv Musculoskelet Dis (2014) 0.78
Rituximab treatment for vasculitis. Clin J Am Soc Nephrol (2010) 0.78
Recent advances in anti-neutrophil cytoplasmic antibody-associated vasculitis. Indian J Nephrol (2016) 0.76
Rituximab in immunologic glomerular diseases. MAbs (2012) 0.76
Low immunoglobulin levels increase the risk of severe hypogammaglobulinemia in granulomatosis with polyangiitis patients receiving rituximab. BMC Musculoskelet Disord (2016) 0.75
A Case of Rituximab Use as an Induction and Maintenance of Remission in ANCA-Associated Vasculitis. Case Rep Rheumatol (2016) 0.75
Place in therapy of rituximab in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis. Immunotargets Ther (2015) 0.75
The Search for a Biomarker of Relapse in ANCA-Associated Vasculitis. J Am Soc Nephrol (2016) 0.75
Recent advances in understanding and treating vasculitis. F1000Res (2016) 0.75
Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med (1992) 13.29
Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med (1983) 8.26
A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med (2003) 7.30
Monoclonal antibody therapy for B-cell non-Hodgkin's lymphoma. N Engl J Med (2008) 4.04
Azathioprine or methotrexate maintenance for ANCA-associated vasculitis. N Engl J Med (2008) 3.66
Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum (2005) 3.35
A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS). Arthritis Rheum (2001) 3.15
Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial. Am J Respir Crit Care Med (2005) 3.04
Treatment of antineutrophil cytoplasmic antibody associated vasculitis: a systematic review. JAMA (2007) 2.91
Consensus statement on the use of rituximab in patients with rheumatoid arthritis. Ann Rheum Dis (2006) 2.07
Antineutrophil cytoplasmic antibodies. Lancet (2006) 2.06
Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis. Rheumatology (Oxford) (2007) 1.95
Delayed-onset peripheral blood cytopenia after rituximab: frequency and risk factor assessment in a consecutive series of 77 treatments. Leuk Lymphoma (2006) 1.88
A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum (2009) 1.74
Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab. J Intern Med (2005) 1.60
Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab. Rheumatology (Oxford) (2006) 1.53
Development and validation of a disease extent index for Wegener's granulomatosis. Clin Nephrol (2001) 1.51
Rituximab in refractory antineutrophil cytoplasmic antibody-associated vasculitis: what is the current evidence? Nephrol Dial Transplant (2006) 1.48
Reactivation of hepatitis B virus following rituximab-based regimens: a serious complication in both HBsAg-positive and HBsAg-negative patients. Ann Hematol (2009) 1.46
Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann Intern Med (1997) 1.40
Review article: Progress of treatment in ANCA-associated vasculitis. Nephrology (Carlton) (2009) 1.28
The late adverse events of rituximab therapy--rare but there! Leuk Lymphoma (2009) 1.17
B-cell recovery following rituximab-based therapy is associated with perturbations in stromal derived factor-1 and granulocyte homeostasis. Blood (2005) 1.08
Safety of biologic therapy in rheumatoid arthritis and other autoimmune diseases: focus on rituximab. Semin Arthritis Rheum (2008) 1.08
Adverse effects of therapy for ANCA-associated vasculitis. Best Pract Res Clin Rheumatol (2009) 1.07
Rituximab as rescue therapy in anti-neutrophil cytoplasmic antibody-associated vasculitis: a single-centre experience with 15 patients. Nephrol Dial Transplant (2008) 1.04
Adjunction of rituximab to steroids and immunosuppressants for refractory/relapsing Wegener's granulomatosis: a study on 8 patients. Clin Exp Rheumatol (2007) 0.94
Late-onset neutropenia following rituximab treatment in patients with autoimmune diseases. Br J Dermatol (2007) 0.92
Effects of anti-CD20 monoclonal antibody as a rescue treatment for ANCA-associated idiopathic systemic vasculitis with or without overt renal involvement. Clin Exp Rheumatol (2008) 0.89
B-cell depletion in Wegener's granulomatosis. Clin Rev Allergy Immunol (2008) 0.85
Targeting B lymphocytes as therapy for ANCA-associated vasculitis. Rheum Dis Clin North Am (2007) 0.83
ANCA-associated vasculitides: pathogenetic aspects and current evidence-based therapy. J Autoimmun (2009) 0.82
Advances in management of rheumatic disease. 1965 to 1985. Arch Intern Med (1989) 0.82
Contaminated cocaine and antineutrophil cytoplasmic antibody-associated disease. Clin J Am Soc Nephrol (2011) 1.52
Long-term maintenance therapy using rituximab-induced continuous B-cell depletion in patients with ANCA vasculitis. Clin J Am Soc Nephrol (2014) 1.28
Serial ANCA titers: useful tool for prevention of relapses in ANCA-associated vasculitis. Kidney Int (2003) 1.17
Hypotheses on the etiology of antineutrophil cytoplasmic autoantibody associated vasculitis: the cause is hidden, but the result is known. Clin J Am Soc Nephrol (2007) 1.00
Continuous renal replacement therapy outcomes in acute kidney injury and end-stage renal disease: a cohort study. Crit Care (2013) 0.96
Trojan horses: drug culprits associated with antineutrophil cytoplasmic autoantibody (ANCA) vasculitis. Curr Opin Rheumatol (2014) 0.92
Prevalence of antineutrophil cytoplasmic antibodies in patients with various pulmonary diseases or multiorgan dysfunction. Arthritis Rheum (2003) 0.86
Fetal outcomes after rituximab exposure in women with autoimmune vasculitis. Ann Rheum Dis (2013) 0.77
Evaluation and treatment of vasculitis in the critically ill patient. Crit Care Clin (2002) 0.76
Antineutrophil cytoplasmic antibodies, autoimmune neutropenia, and vasculitis. Semin Arthritis Rheum (2011) 0.75
Opportunistic infections are preceded by a rapid fall in antineutrophil cytoplasmic antibody (ANCA) titer in patients with ANCA associated vasculitis. J Rheumatol (2002) 0.75
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 30-2002. An eight-year-old girl with fever, hemoptysis, and pulmonary consolidations. N Engl J Med (2002) 0.75
Case records of the Massachusetts General Hospital. Case 21-2014. A 68-year-old man with a sudden onset of diplopia. N Engl J Med (2014) 0.75